-
1
-
-
34347402091
-
Clinical experience with Hemopure
-
South Africa
-
Levien LJ. South Africa. Clinical experience with Hemopure. ISBT Science Series. 2006;1:167-173.
-
(2006)
ISBT Science Series
, vol.1
, pp. 167-173
-
-
Levien, L.J.1
-
2
-
-
0002813725
-
Overview of preclinical and clinical efficiency of Biopure's HBOCs
-
Chang TMS (ed.). New York, Karger Landes Systems
-
Pearce LB, Gawryl S: Overview of preclinical and clinical efficiency of Biopure's HBOCs; in Chang TMS (ed.).Blood substitutes: Principles, Methods, Products and Clinical Trials. New York, Karger Landes Systems. 1998:82-100.
-
(1998)
Blood Substitutes: Principles, Methods, Products and Clinical Trials
, pp. 82-100
-
-
Pearce, L.B.1
Gawryl, S.2
-
3
-
-
0029411044
-
Haematological effects of a novel haemoglobin based oxygen carrier in normal male and female subjects
-
Hughes GS, Francom SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, Jacobs EE. Haematological effects of a novel haemoglobin based oxygen carrier in normal male and female subjects. J Lab Clin Med. 1995;126:444-451.
-
(1995)
J Lab Clin Med
, vol.126
, pp. 444-451
-
-
Hughes, G.S.1
Francom, S.F.2
Antal, E.J.3
Adams, W.J.4
Locker, P.K.5
Yancey, E.P.6
Jacobs, E.E.7
-
4
-
-
34249995380
-
Alternatives to allogeneic blood transfusions
-
DOI 10.1016/j.bpa.2007.02.004, PII S1521689607000201, Blood Transfusion
-
Pape A, Habler O. Alternatives to allogeneic blood transfusions. Best Practice and Research Clinical Anaesthesiology. 2007;21(2):221-239. (Pubitemid 46888189)
-
(2007)
Best Practice and Research in Clinical Anaesthesiology
, vol.21
, Issue.2
, pp. 221-239
-
-
Pape, A.1
Habler, O.2
-
5
-
-
44249093233
-
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis
-
DOI 10.1001/jama.299.19.jrv80007
-
Natanson C, Kern SJ, Lurie P et al. Cell-Free Haemoglobin-Based blood substitutes and risk of myocardial infarction and Death: A Meta-Analysis. JAMA. 2008;299(19):2304-2312. (Pubitemid 351724397)
-
(2008)
JAMA - Journal of the American Medical Association
, vol.299
, Issue.19
, pp. 2304-2312
-
-
Natanson, C.1
Kern, S.J.2
Lurie, P.3
Banks, S.M.4
Wolfe, S.M.5
-
7
-
-
51949117668
-
Hemoglobin-based blood substitutes and risk of myocardial infarction and death
-
Levien LJ, Hodgson RE, James MFM. Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death. JAMA. 2008;300(11):1295.
-
(2008)
JAMA
, vol.300
, Issue.11
, pp. 1295
-
-
Levien, L.J.1
Hodgson, R.E.2
James, M.F.M.3
-
8
-
-
51949086733
-
Hemoglobin-based blood substitutes and risk of myocardial infarction and death
-
Keipert PE, Olofsson C, Winslow RM. Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death. JAMA. 2008;300(11):1295-1296.
-
(2008)
JAMA
, vol.300
, Issue.11
, pp. 1295-1296
-
-
Keipert, P.E.1
Olofsson, C.2
Winslow, R.M.3
-
9
-
-
33746462251
-
Current status of oxygen carriers: 2006
-
Winslow RM: Current status of oxygen carriers: 2006 Vox Sanguinis. 2006;91:102-110.
-
(2006)
Vox Sanguinis
, vol.91
, pp. 102-110
-
-
Winslow, R.M.1
|